This retrospective database study of44,862 pati ents who had a history of a primal }' head and neck mali gnancy was conducted to identify any clinical variables that may predict the occurrence ofa seco nd primal}' head and neck malignancy. During a mean fo llow-up of42.2 months, a second head and neck primary developed in 94J ofthese patients (2.J%). Statistical analyses revealed that a higher incidence ofa seco nd primal )' was associated with increased age and a location ofthe fi rst prim ary in the laryn x/h ypopharynx, the oropha rynx, a maj or salivary gland, or the nasopharynx. A lower incidence was associated with the presence ofcervica l nodal disease or treatment ofthe fi rst prim al)' with radiation therapy. Factors that had no effec t on the risk of a seco nd primal }' included sex, the size of the fi rst primal)' tum or; a first -primary site in the oral cavity, and treatm ent of the fir st primal }' with cance r-directed surgery. The risk of a second primal }' head and neck cance r remain ed constant fo r at least J0 years.
Introduction
More than 50 ,000 new cases of head and neck cancer are diagnosed each year in the United States.' The vast majority of these tum ors will dem onstrate squamo us cell carcinoma histology. Becau se tobacco ex pos ure and alcohol use are stro ngly synergistic in the prom otion of these tumors at multiple sites in the head and neck , patient s with an initi al head and neck ca ncer are face d wit h a long-term risk of developin g a seco nd prim ary mal ignancy.' A seco nd primary typicall y develop s in the upp er aerodigestive tract, eso phag us, or lung.' Th e reported incidence ran ges from 2 to 17%, dependin g o n patient character istics and the du ration of fo llow-up'?
Onc e a pati ent has been diagno sed with and treated for a head and neck cancer, a frequent and rigo rous posttreatment follow-up is often undert aken .vClose follow-up is advi sabl e for two reason s: ( I) to dete ct a local or regional recurrence of the index ca ncer as early as possibl e and (2) to identify a seco nd prim ary malignancy as soo n as possible. It is widel y held that early dete ction of a recurrenc e or a second primary affords a better chance for sa lvage and cure.' As patients survive beyond the actuarial 5-year mark , the emphasis of fo llow-up ge nerally shifts toward dete cting a seco nd prim ary rather than a recurre nce . How ever, the need for rigorous follow-up ofall patients with head and neck cance r to detect a seco nd primary has been questioned.' Efficient allocation of follow-up resour ces-including surveillance endoscopy, imaging studies, and other modalitie s-would be furthered if we could identify particular clini cal risk fact ors for the dev elopment of a second primary.
Th e study described herein was undertaken from an epidemiologic standpoint to dete rmine if certain clinical factors pre sent at the time of the initial presentation of the ind ex primary head neck malign ancy might serve as mark ers to identify patient s who are at higher risk for a seco nd primary malignancy of the head and neck .
Patients and methods
Th e patient s in this study had been entered into the Surveilla nce Epid emi ology and End Results database between Jan. I, 1988, and Dec. 3 1, 1999. 8 Th e author has used thi s database for other studies of epide miology and surviva l in patient s with several types ofhead and neck malignancy.":" Data were obtained on prim ary ca nce rs that had arisen in the ora l cav ity, larynx/hypoph aryn x, oropharynx, nasopharyn x, major salivary g lands, nose, nasal cav ity, and middl e ear. Inde x (first) upp er aerodiges tive tract prim aries occ urring in the cer vical eso phag us and trache a were not included in this study.
Th e author conducted two data extractions. The first included all cases of head and neck ca ncer at the sites under study in which patients had only one primary; these patients served as the control group. The second data Table 1 . Distribution of primary sites among the entire study population extraction included all patients with a prima ry head and neck cancer who subseq uently developed one (and only one) head and neck primary at a site under study; patients whose second primary arose in the eso phag us, trachea, or lung were excluded fro m this ana lysis.
The two data sets were merged and importe d into Microsoft Exce l software. Patients in the contro l gro up who had less than 3 mo nths of follow-u p and patients in the seco nd-primary group whose seco nd primary had been diagnosed withi n 3 month s of the first primary were excluded from the study to avoi d the pos sibility of including patien ts who had purely sy nchro nous primaries that may have been treated simultaneously. In addition to the site of the first prima ry, other potenti al predictor variab les under considera tion were the patient's sex, age at first diag nosis, the size of the first primary tumor, the presence of cervical nodal disease, treatm ent with ca ncer-directed surgery, and treatment with radiation therapy. Eac h of these varia bles referred to the clini cal presentation of the first primary because data on these variables would have been available to the clinicia n responsible for follow -up survei llance prior to the presentati on of a seco nd primary. Overall survival time and the tim e to diagnosis of a second primary were also reco rded . Data were then ex ported to SPSS version 10.0 sta tistical software, and standard descriptive statistic s were comp uted for the two cohorts. Survival time prior to the developme nt of a seco nd primary was co mputed in acco rda nce with the Kaplan-Meier method . Univariate statistical analys is was co nducted for the influence of clinical predictor var iables on the development of a seco nd primary by using Pearson's chi-square test or the Student's t test as approp riate. Cox proportional hazards regre ssion analysis was then conducted to determine the multi variate significa nce of the different potent ial clinical predictor varia bles. Missing predictor variables were replaced with the covariate mean . The proportional hazard s model was co nducted with a backward likelih ood ratio, and significa nce thresholds at entry and exi t were set at 0.10 and 0.05, respecti vely. For clini cally significant predictor varia bles, 95 % co nfidence intervals for the hazard were computed .
Results
A total of 44,862 patients (mea n age : 60.9 yr; 70. 3% male) in the database met the incl usion criteria (table I) . Of this gro up, 43 ,92 1 patient s (97.9 %) did not develop a seco nd primary during a mean follow -up of 43.9 months, whereas the rem aining 94 1 patient s (2. 1%) did develop a seco nd head and neck primary durin g a mean follow-up of 42.2 month s; the difference in the mean length of follow -up was not statistically sig nificant (p =0.113, Student's t test).
Th e resu lts of uni variate statistica l analysis sugges t that eac h of the clin ical variables may indee d have had so me predictive value in asse ssi ng the risk of a second primary malignancy (table 2) . Th e Kaplan -Meier hazard rate for development of a seco nd primary co ntinued to increase almost linearly with increasing follow-up (surv ival) fro m the time of the first primary and continued beyo nd 10 years of follow-up (figure) .
Factors associated with a high er risk. Th e res ults of the Cox proporti onal hazard s analysis revealed that several fac tors did indeed co nfer a sig nificant ly grea ter risk of developing a second primary (table 3) . Among these was the location of the first primary in the larynx/hypophar ynx (hazard ratio [HR]: 7.9 I9), the oropharynx (HR: 5.95 1), a 
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maj or sa livary gland (HR: 3.86 1), or the nasopharynx (HR: 2.073) .Another risk factor was gre ater age at diagnosis of the index primary (HR: 1.012), although this association was weak.
Factors associated with a lower risk. A lower risk of a seco nd primary was associated with treatm ent of the first prim ary with radiati on therapy (HR: 0.777 ) and with the presence of nodal disease at presentation of the first primary (HR: 0.955 ), although the latter assoc iation was statistically wea k.
Factors not associated with risk.
Sex , the size oft he first primary tumor, a first-prim ary site in the ora l cav ity, and treatm ent of the first primary with ca ncer-direc ted surgery had no influence on the risk of a seco nd primary. 
Discussion
Despite advances in radiation therapy, ch em oth er ap y, and rec on structi ve methods, overall survival for head and neck ca ncer patients has not improved dramatically durin g the past 20 yea rs." Th e increase d risk for the developm ent ofa second prim ary cance r in the head neck among patient s who have already undergon e successful treatm ent of a first primary head and neck can cer is related to factors such as "field ca nce rization " and co ntinued tobacco and alco hol use." Follow-up of head neck ca nce r patients is ofte n sched-uled for set intervals and may continue well beyond 5 yea rs afte r diagnosis and treatment of the first primary ca ncer." However, such follow-up is time-consumin g and expens ive. In fact, the need for rigorou s follow-up has been the topi c of debate in the literature. For example, Haughey et al used the result s of their meta-analysis to make a pointed case for an endoscopic screening protocol to prom ote early detect ion of second tumors in head and 15 Other authors have recommended less intense follow-up, with the frequency of clinic visit s guided by patients' symptoms." A better strategy would be to base follow-up on the presence or absence of each patient's risk factors for developing a second mal ignancy. Patients at high risk for a second primary could then be followed more closely than patients deemed to be at low risk. Implementation of such a strategy would require reliable data on pertinent risk factors. Obviously, risk stratification would need to be undertaken for an individual patient at the time of the diagnosis of the first primary in order to prospectively program subsequent follow-up.
Factors associated with a higher risk. In the study described herein , it is not surprising that first primaries located in the larynx/hypopharynx and in the oropharynx were associated with a higher risk for a second primary. Both hazard ratios were rather high-7.919 and 5.951 , respectively. This finding is very much in concert with the theory of field cancerization or "condemned mucosa," which was popularized by Slaughter et al .'? Patients who develop primary malignancies at these site s are likely to experience local field changes beyond the area of surgical exc ision and/or radiation therapy, and these changes may subsequently mature into mucosal malignancy.
The significantly higher hazard ratio for laryngeal! hypopharyngeal first primaries is especially worth noting. The most abundant data regarding the incidence of second neoplasms in head and neck cancer specifically relate to patients with a laryngeal index primary.':" Higher rates of a second primary malignancy (4.8 to 8.2 % higher) in patients with a laryngeal first primary have been reported by others, including Nikolaou et al.' Yamamoto et aI, in a large study of the site-dependent specificity of second primary tumors, identified the larynx and the oropharynx as the index primary sites most likely to be associated with a second primary.' Quite often , the second primary will appear in the respiratory tract, usually the lung.P:" The present study did not examine the risk of second primaries outside of the head and neck because the study 's focus was on otolaryngology, and therefore follow-up of esophageal and lung second primaries was out side the scope of this study. Nonetheless, it is extremely important to remember that there is a risk for a second primary in the esophagus (most often after a pharyngeal first primary) and in the lung.
In the present study, it was somewhat surprising that patients with a salivary gland first primary were also more likely to develop a second primary; the reason forthis is not intuitively clear, and this finding may merit further study. Less of a surprise was the association between increased risk and nasopharyngeal carcinoma. Smoking is a wellknown risk factor for both nasopharyngeal carcinoma and the development of a second primary." Still , the hazard ratio for nasopharyngeal carcinoma was relati vely small 124 (2.073), a finding that is con sistent with tho se of previous studies .' Nevertheless, patients with nasopharyngeal carcinoma should be followed closely.
Factors associated with a lower risk. The apparent protective effect of radiation therapy may be attributable to the fact that irradiation treats not only the site of the first primary, but it "pretreats" adjacent areas offield cancerization , thereby preventing many second primaries.
The lower risk associated with the presence of nodal disease is more difficult to understand. It is possible that patients with nodal disease received irradiation overa wider area and therefore received a similar benefit in adjacent mucosal areas .
Duration ofincreased risk. In one ofthe largerpublished series with adequate follow-up of head neck cancer patients, Leon et al reported that the risk of a second neoplasm is approximately 4% per year, and this risk persists well beyond 5 years after the index diagnosis." The results ofthe present study reinforce the continuation of the extended risk. The percentage of second primary tumors encountered in the present study (2.1%) is slightly lower than that reported in the literature because this study did not include patients who had two or more subsequent head and neck second primaries . And again , the present study also excluded patients whose second primary neoplasms arose in the esophagus, lung, and elsewhere out side the head and neck.
Other predictors. Other investigators have attempted to use other biologic markers to determine the relative risk of a second head and neck primary. For example, Schantz et al demonstrated that sensitivity to chromatid breaks of lymphocytes treated with bleomycin was one such marker," Shin et al showed that p53 was not a reliable marker." Currently, most marker studies are experimental and cannot be easily applied to most humans with head and neck cancer, but they may hold some promise in the future.
One potential drawback to the present study is that data were not available regarding the history of tobacco and alcohol use leading up to the index primary or during the interval between primaries. It is well known that continued smoking and alcohol use significantly elevate the risk for a second primary malignancy within the head and neck.' Certainly, data on these social habits would be useful in determining the need for closer clinical follow-up of patients diagnosed with a first head and neck primary. The predictor var iables analyzed in this study were those that were available to the otolaryngologist immediately following the diagnosis and treatment of the first primary, and they are therefore fixed. Smoking and alcohol intake are modifiable (and in head neck cancer patients, often continuously changing) risk factors for the development of a second primary, and they should be reassessed at regularly scheduled intervals during follow-up. Because these social habits are so variable during follow-up, it is difficult to include them in any predictive model. However, they should not be ignored. have suggested that a finding ofcongenital midline cervica l cleft should prompt a search for other midline lesions, but there is no standard for preoperative ev aluation.t4
Treatment entails complete surgical exc ision of the cle ft and sinus tract with closure via multipl e Z-plasties (simple closures tend to lead to co ntrac ture) .t7 Cases in which the underlying fibrous cord is not completely exc ised tend to recur.15 Some authors have suggested the use of a few large Z-plasties rather than many smaller ones. Th e oblique limbs of the Z-plasty clos ure are more prone to hypertrophi c scarring. If scarring does occur, it can be treated with intralesiona l steroid injections and massage. Early treatment in patients without severe deformity has produced goo d functional and acce ptable cosmetic result s. If torticollis is present, early treatment should be considere d to reduce the risk of contracture and the development of mandi bular exostoses .
